ISLAMABAD, Feb 9 (Reuters) - Russia's Sputnik-V has become
the third COVID-19 vaccine to be approved by Pakistan for
emergency use after China's Sinopharm and the one developed by
AstraZeneca and Oxford University, the country's health minister
said on Tuesday.
"Sputnik has received EUA (emergency use authorisation),"
the minister, Faisal Sultan, told Reuters in a WhatsApp text
message.
Another candidate, developed by CanSino Biologics
Inc(CanSinoBIO), has also completed clinical trials in the South
Asian nation of 220 million people.
(Reporting by Asif Shahzad
Editing by Gareth Jones
Editing by Gareth Jones)